Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hainan Shennong Seed Industry Technology
300189
5
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
US Stock MarketDetailed Quotes
SYRA Syra Health
- 0.1900
- +0.0019+1.01%
Trading Apr 7 12:49 ET
3.73MMarket Cap-0.38P/E (TTM)
0.1994High0.1640Low251.20KVolume0.1880Open0.1881Pre Close46.33KTurnover2.85%Turnover RatioLossP/E (Static)19.65MShares2.270052wk High1.29P/B1.68MFloat Cap0.130652wk Low--Dividend TTM8.83MShs Float8.3700Historical High--Div YieldTTM18.82%Amplitude0.1306Historical Low0.1840Avg Price1Lot Size
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Syra Health Stock Forum
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
Tuesday, 1st April at 5:00 pm
CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from th...
Syra Health's $660K Contract Extension Signals Major Growth in Population Health Services
Syra Health Secures $660,000 Population Health Contract Extension
Thursday, 13th March at 8:55 am
CARMEL, Ind., March 13, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today a one-year, $660,000 Population Health contract extension with a national healthcare organization. This agreement, combined with the previous year's agreement...
8-k filed beating earnings.
Syra Health's strategic repositioning toward higher-margin Population Health and Behavioral/Mental Health services represents a prescient market alignment with today's healthcare priorities. The 132% growth in Population Health revenue indicates strong product-market fit in a segment where data analytics and epidemiology expertise command premium pricing.
The company's contract success with multiple state health departments highlights an often-...
Syra Health's 45% revenue growth to $8.0 million demonstrates strong business momentum in a challenging healthcare market. The standout performer is their Population Health segment, which more than doubled with 132% YoY growth and accelerated to 285% growth in Q4. This strategic shift toward higher-margin business units is already showing significant operational improvements, evidenced by Q4 net losses being cut nearly in half year-over-year.
The company...
No comment yet